Abstract

Purpose:Spreading from China, COVID-19 pandemic reached Italy, the first massively involved western nation. At the beginning of March, 2020 in Northern Italy a complete lockdown of activities was imposed. Access to all healthcare providers, was halted for patients with elective problems. We present the management experience of the Humanitas Clinical and Research Center Ophthalmology Department in Rozzano, Milan, Italy, during the lockdown.Methods:Containment measures were taken to reduce viral transmission and identify infected patients. All planned visits were canceled but for those not deferrable. Social distancing was introduced reducing number of visits per hour. Minor surgery for progressive pathologies was continued. As the lockdown prolonged, we reorganized patient care. All canceled cases were evaluated by electronic medical records analysis and telephonic triage, to identify, recall, and visit patients at risk of vision loss.Results:From March 9, to April 30, 2020 we performed a total of 930 visits and 612 exams. Some visits (n = 698) and exams (n = 160) were deemed as necessary for continuity of care and performed as planned. Among the remaining 1283 canceled appointments, after evaluation 144 visits and 32 instrumental exams were classified as urgent and rapidly rescheduled. Performed surgical activities were limited to corneal collagen cross linking (n = 39) and intravitreal injections (n = 91), compared to 34 and 94, respectively, in the same period of 2019.Conclusion:In-office activities deemed not deferrable were performed safely. The recall service was highly appreciated by all patients. No patient or staff member reported symptoms of COVID-19.

Highlights

  • On December 2019 first cases of pneumonia associated to a new coronavirus appeared in Wuhan, capital of Hubei in China.[1]

  • Relatives referred that two patients had succumbed to COVID-19 infection

  • The first reported case of COVID-19 in Italy was on February 21st 2020.18 Infection spread rapidly in the Nation, heavily involving the North and the regions of Lombardy, Veneto and Emilia Romagna, with more than 200,000 infected patients and more than 28,000 casualties by the end of April.[18]

Read more

Summary

Introduction

On December 2019 first cases of pneumonia associated to a new coronavirus appeared in Wuhan, capital of Hubei in China.[1] Rapidly, its high infectivity and severity characterized this disease as an emergency. The name “COVID19” (coronavirus disease 2019) was proposed by the World Health Organization (WHO)[2] but it has been named “severe acute respiratory syndrome coronavirus 2” (SARS – CoV-2).[3] The transmission of COVID-19 occurs from person to person through respiratory droplets, direct contacts, and fomites. Airborne aerosol and oral-fecal transmission remain to be confirmed.[4] Incubation period of the acute severe respiratory infection is usually between 1 and 14 days.[5] Most commonly, symptoms include fever, European Journal of Ophthalmology 00(0)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call